Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Oct 7, 2026, 7:02 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 49–72 of 1,385 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Emergency Departments Clear all

Conditions: Dizziness, Vertigo
Interventions: Vestibular Rehabilitation, Usual Care; Behavioral · Other
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 125 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Safety Issues
Interventions: Emergency Manual (Crisis Checklist); Behavioral
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2019
U.S. locations: 3
States / cities: Boston, Massachusetts

Conditions: Hypertension
Interventions: Remote Blood Pressure Monitoring + Telehealth, Usual care; Other
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Atrial Fibrillation and Flutter
Interventions: Diltiazem Oral Product, Diltiazem Injectable Product; Drug
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years and older
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Covid19, Infectious Disease, SARS-CoV Infection
Interventions: Observational; Other
Lead sponsor: George Washington University; Other
Eligibility: 18 Years to 100 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Heart Failure, Acute Heart Failure
Interventions: Protocolized diuretic therapy; Drug
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 19 Years and older
Enrollment: 474 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 2
States / cities: Nashville, Tennessee

Conditions: Sepsis
Interventions: PRESS Intervention; Behavioral
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 984 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 3
States / cities: Atlanta, Georgia • Iowa City, Iowa • St Louis, Missouri

Conditions: Emergencies, Satisfaction, Patient, Expectations, Physician-Patient Relations
Interventions: Emergency Department Visit Expectations Questionnaire; Other
Lead sponsor: Orange Park Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 308 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Orange Park, Florida

Conditions: Type 2 Diabetes Mellitus, Hyperglycemia
Interventions: Diabetes Pathway; Other
Lead sponsor: Medstar Health Research Institute; Other
Eligibility: 21 Years to 75 Years
Enrollment: 419 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Anxiety, Panic Attacks
Interventions: CalmiGo; Device
Lead sponsor: Yves Duroseau; Other
Eligibility: 18 Years and older
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Manhattan, New York

Conditions: Coronary Artery Disease
Interventions: FFR-CT; Diagnostic Test
Lead sponsor: HeartFlow, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022
U.S. locations: 2
States / cities: Worcester, Massachusetts • Cleveland, Ohio

Conditions: Migraine
Interventions: PMR (Progressive muscle relaxation therapy), Monitored Usual Care (MUC); Behavioral
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 65 Years
Enrollment: 112 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: New York, New York

Conditions: Adverse Childhood Experiences
Interventions: In-person therapy, Telehealth therapy; Behavioral
Lead sponsor: Emory University; Other
Eligibility: 12 Years to 17 Years
Enrollment: 62 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 4
States / cities: Atlanta, Georgia

Conditions: Chest Pain
Interventions: Two consecutive 15-lead ECGs; Diagnostic Test
Lead sponsor: Nihon Kohden; Industry
Eligibility: 18 Years and older
Enrollment: 314 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 2
States / cities: Manhasset, New York • New Hyde Park, New York

Conditions: Antimicrobial Stewardship, Acute Bronchitis, Upper Respiratory Infection
Interventions: Antibiotic Stewardship; Behavioral
Lead sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center; Other
Eligibility: 21 Years and older
Enrollment: 134 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Acute Asthma
Interventions: Tailored asthma management program, Generic web-based education; Behavioral
Lead sponsor: Henry Ford Health System; Other
Eligibility: 13 Years to 19 Years
Enrollment: 126 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 2
States / cities: Detroit, Michigan

Conditions: Postdural Puncture Headache
Interventions: Sphenopalatine Ganglion Block, Placebo; Procedure
Lead sponsor: University of Arkansas; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Carbon Monoxide Intoxication
Interventions: Observational data collection.; Device
Lead sponsor: Nonin Medical, Inc; Industry
Eligibility: 18 Years and older
Enrollment: 82 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Saint Paul, Minnesota

Conditions: Abscess
Interventions: Standard of Care (SoC), Irrisept Delivery System; Device
Lead sponsor: Irrimax Corporation; Industry
Eligibility: 12 Years and older
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Abscess
Interventions: Bedside emergency ultrasound; Device
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 2 Months to 18 Years
Enrollment: 420 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Emergency Service, Hospital, Behavior Change Interventions
Interventions: Contact your PCP, Use Intelligent Triage; Behavioral
Lead sponsor: Geisinger Clinic; Other
Eligibility: 18 Years and older
Enrollment: 8,286 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Danville, Pennsylvania

Conditions: Vomiting, Nausea, Children, Only
Interventions: Inhaled Isopropyl Alcohol, Oral Ondansetron, Inhaled Placebo; Other · Drug
Lead sponsor: State University of New York at Buffalo; Other
Eligibility: 7 Years to 17 Years
Enrollment: 84 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Heart Failure, Congestive, Cardiomyopathy
Interventions: recombinant B-type, natriuretic peptide, placebo; Drug
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 104 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2005
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Text Messaging
Interventions: Text Messaging; Behavioral
Lead sponsor: University of Iowa; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Iowa City, Iowa

Search by objective public record fields.

Emergency Department Vestibular Rehabilitation Therapy for Dizziness and Vertigo

Using Emergency Manuals During Interprofessional Crisis Management: Are There Unintended Consequences?

Monitoring Blood Pressure at Home

Oral vs Intravenous Diltiazem for Rapid Atrial Fibrillation/Flutter Trial

Performance of a Remote Monitoring Program for Patients Diagnosed With COVID-19

Randomized Controlled Trial of urinE chemiStry Guided aCute heArt faiLure treATmEnt (ESCALATE)

Impact of a Prehospital Sepsis Protocol on Timely Antibiotic Administration and Subsequent Adverse Events

Influence of a Questionnaire on Patients' Emergency Room Expectations

MedStar Health Type 2 Diabetes Pathway to Control

Using CalmiGo to Manage Anxiety and Panic Attack Symptoms in the Emergency Department

Assessing Diagnostic Value of Non-invasive FFR-CT in Coronary Care in the Emergency Department

Improving Health Outcomes of Migraine Patients Who Present to the Emergency Department

ACEs Referral From PED

Evaluation of Synthesized 18-Lead ECG in the Emergency Department

Using Behavioral Science to Reduce Inappropriate Antibiotic Use in Acute Care Settings

Feasibility of an ED Initiated Online Asthma Management Program for Urban Teens

Sphenopalatine Ganglion Block for Postdural Puncture Headache in the Emergency Department

Suspected Cases of Carbon Monoxide Poisoning

The Effect of Wound Irrigation With Irrisept on Abscess Healing (Irrisept UF Study)

Emergency Bedside Ultrasound for Pediatric Soft Tissue Infections

Informing Low-acuity Emergency Department Patients of Non-emergent Resources (2)

Inhaled Isopropyl Alcohol for Treatment of Nausea

Impact of Nesiritide Infusion for Decompensated Heart Failure in the Emergency Department

Text Messaging Follow-up From ED